Literature DB >> 11709521

Sodium homeostasis with chronic sodium loading in preascitic cirrhosis.

F Wong1, P Liu, L Blendis.   

Abstract

BACKGROUND: Preascitic cirrhotic patients receiving 200 mmol of sodium daily for seven days remain in positive sodium balance. Thereafter, sodium handling is unknown. AIM: To assess renal sodium handling in preascitic cirrhosis on a high sodium diet for five weeks.
METHODS: Sixteen biopsy proven preascitic cirrhotics were assessed at weekly intervals for five weeks on a diet of 200 mmol sodium/day using a daily weight diary and weekly 24 hour urinary sodium estimations. Fasting supine neurohormone levels were measured at baseline and weekly for five weeks while haemodynamics were measured at baseline and at five weeks.
RESULTS: The daily diet of 200 mmol of sodium resulted in weight gain and a positive sodium balance for three weeks, associated with significant suppression of plasma renin activity and aldosterone levels, and a significant rise in plasma atrial natriuretic peptide levels (p<0.05). Patients' weights plateaued during week 4, associated with complete sodium balance and significant suppression of plasma noradrenaline levels (p<0.05). This was followed by a negative sodium balance and weight loss, and finally complete sodium balance, again despite a mean net gain of 2.3 (0.3) kg, associated with a return of plasma renin activity and aldosterone levels to within normal ranges. The lack of increase in central blood volume in addition to the persistent increase in plasma atrial natriuretic peptide levels indicated that residual volume expansion, consequent to persistent weight gain, was distributed on the venous side of the circulation. No free fluid was seen on repeat abdominal ultrasound after five weeks.
CONCLUSION: Preascitic cirrhotics have a natriuretic "escape" after three weeks on high sodium dietary intake, associated with elevated plasma atrial natriuretic peptide levels and suppression of the renin-angiotensin-aldosterone system. With continued suppressed sympathetic activity, preascitics re-establish complete sodium balance but with a net weight gain and presumed increased intravascular volume, but without ascites. This further elucidates the compensated sodium retaining abnormality that characterises preascitic cirrhosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11709521      PMCID: PMC1728551          DOI: 10.1136/gut.49.6.847

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  30 in total

1.  Reduction in hepatic venous pressure gradient as a consequence of volume contraction due to chronic administration of spironolactone in patients with cirrhosis and no ascites.

Authors:  H Okumura; T Aramaki; Y Katsuta; K Satomura; M Akaike; T Sekiyama; H Terada; M Ohsuga; H Komeichi; H Tsutsui
Journal:  Am J Gastroenterol       Date:  1991-01       Impact factor: 10.864

2.  The response of atrial natriuretic factor and sodium excretion to dietary sodium challenges in patients with chronic liver disease.

Authors:  L C Warner; P J Campbell; G A Morali; A G Logan; K L Skorecki; L M Blendis
Journal:  Hepatology       Date:  1990-09       Impact factor: 17.425

3.  Mineralocorticoid escape in patients with compensated cirrhosis and portal hypertension.

Authors:  G La Villa; J M Salmerón; V Arroyo; J Bosch; P Ginés; J C García-Pagán; A Ginés; M Asbert; W Jiménez; F Rivera
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

4.  Na restriction blunts expansion of plasma volume and ameliorates hyperdynamic circulation in portal hypertension.

Authors:  P Genecin; J Polio; R J Groszmann
Journal:  Am J Physiol       Date:  1990-09

5.  Electrochemical detection of catecholamines in urine and plasma after separation with HPLC.

Authors:  H Weicker; M Feraudi; H Hägele; R Pluto
Journal:  Clin Chim Acta       Date:  1984-08-15       Impact factor: 3.786

6.  Reduced central blood volume in cirrhosis.

Authors:  J H Henriksen; F Bendtsen; T I Sørensen; C Stadeager; H Ring-Larsen
Journal:  Gastroenterology       Date:  1989-12       Impact factor: 22.682

7.  Impaired cardiopulmonary response to exercise in moderate hypertension.

Authors:  J M Goodman; P R McLaughlin; M J Plyley; R M Holloway; D Fell; A G Logan; P P Liu
Journal:  Can J Cardiol       Date:  1992-05       Impact factor: 5.223

8.  Circadian variation in renal sodium and potassium handling in cirrhosis. The role of aldosterone, cortisol, sympathoadrenergic tone, and intratubular factors.

Authors:  F Trevisani; M Bernardi; R De Palma; L Pancione; F Capani; M Baraldini; A Ligabue; G Gasbarrini
Journal:  Gastroenterology       Date:  1989-04       Impact factor: 22.682

9.  Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation.

Authors:  M Bernardi; F Trevisani; C Santini; R De Palma; G Gasbarrini
Journal:  Gut       Date:  1983-08       Impact factor: 23.059

10.  Relationship between plasma ANF responsiveness and renal sodium handling in cirrhotic humans.

Authors:  M Epstein; R Loutzenhiser; P Norsk; S Atlas
Journal:  Am J Nephrol       Date:  1989       Impact factor: 3.754

View more
  5 in total

1.  Cardiac response to exercise in cirrhosis.

Authors:  R H Wachsberg
Journal:  Gut       Date:  2002-11       Impact factor: 23.059

2.  Natriuretic and aquaretic effects of intravenously infused calcium in preascitic human cirrhosis: physiopathological and clinical implications.

Authors:  G Sansoè; F Wong
Journal:  Gut       Date:  2007-02-15       Impact factor: 23.059

3.  Altered central TRPV4 expression and lipid raft association related to inappropriate vasopressin secretion in cirrhotic rats.

Authors:  Flávia Regina Carreño; Lisa L Ji; J Thomas Cunningham
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-12-17       Impact factor: 3.619

4.  Sodium handling is associated with liver function impairment and renin-aldosterone axis activity in patients with preascitic cirrhosis without hyponatremia.

Authors:  Dimitris Tzamouranis; Alexandra Alexopoulou; Spyros P Dourakis; George S Stergiou
Journal:  Ann Gastroenterol       Date:  2012

Review 5.  Managing portal hypertension in patients with liver cirrhosis.

Authors:  Tilman Sauerbruch; Robert Schierwagen; Jonel Trebicka
Journal:  F1000Res       Date:  2018-05-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.